These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35786403)

  • 1. Dengue and COVID-19: two sides of the same coin.
    Malavige GN; Jeewandara C; Ogg GS
    J Biomed Sci; 2022 Jul; 29(1):48. PubMed ID: 35786403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021.
    Munoz-Jordan J; Cardona J; Beltrán M; Colón C; Schiffer J; Stewart-Clark E; Zellner B; Semenova V; Li Y; Jia LT; Maniatis P; Pawloski L; Adams L; Paz-Bailey G; Rivera-Amill V; Medina F
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):375-377. PubMed ID: 35271558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19.
    Yong YK; Wong WF; Vignesh R; Chattopadhyay I; Velu V; Tan HY; Zhang Y; Larsson M; Shankar EM
    Front Immunol; 2022; 13():889196. PubMed ID: 35874775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.
    Cheng YL; Chao CH; Lai YC; Hsieh KH; Wang JR; Wan SW; Huang HJ; Chuang YC; Chuang WJ; Yeh TM
    Front Immunol; 2022; 13():941923. PubMed ID: 36045680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19 and dengue: Double punches for dengue-endemic countries in Asia.
    Harapan H; Ryan M; Yohan B; Abidin RS; Nainu F; Rakib A; Jahan I; Emran TB; Ullah I; Panta K; Dhama K; Sasmono RT
    Rev Med Virol; 2021 Mar; 31(2):e2161. PubMed ID: 32946149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection.
    Lin MH; Li D; Tang B; Li L; Suhrbier A; Harrich D
    Microbiol Spectr; 2022 Dec; 10(6):e0394922. PubMed ID: 36445148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-infection of SARS-CoV-2 and dengue virus: a clinical challenge.
    Bicudo N; Bicudo E; Costa JD; Castro JALP; Barra GB
    Braz J Infect Dis; 2020; 24(5):452-454. PubMed ID: 32866435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Arbovirus Antibodies Cross-React With Severe Acute Respiratory Syndrome Coronavirus 2.
    Hunsawong T; Buddhari D; Rungrojcharoenkit K; Suthangkornkul R; Mongkolsirichaikul D; Lohachanakul J; Tayong K; Sirikajornpan K; Rodpradit P; Poolpanichupatam Y; Klungthong C; Utennam D; Kaewhiran S; Cotrone TS; Fernandez S; Jones AR
    Microbiol Spectr; 2022 Dec; 10(6):e0263922. PubMed ID: 36445096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue-COVID-19 coinfection: the first reported case in the Philippines.
    Saipen A; Demot B; De Leon L
    Western Pac Surveill Response J; 2021; 12(1):35-39. PubMed ID: 34094622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
    Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
    Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of SARS-CoV-2 with other pathogens, especially dengue virus: A historical perspective.
    Dutta D; Ghosh A; Dutta C; Sukla S; Biswas S
    J Med Virol; 2023 Feb; 95(2):e28557. PubMed ID: 36755367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Antibodies as Predictor of Severe Dengue among Hospitalized Children with Dengue Illness in the Post-third-wave Period of COVID-19 Infection in India.
    Balasubramani S; Govindaraj V; Agarwal R; Pathania A; Vij A
    J Assoc Physicians India; 2022 Sep; 70(9):11-12. PubMed ID: 36082886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses.
    Lustig Y; Keler S; Kolodny R; Ben-Tal N; Atias-Varon D; Shlush E; Gerlic M; Munitz A; Doolman R; Asraf K; Shlush LI; Vivante A
    Clin Infect Dis; 2021 Oct; 73(7):e2444-e2449. PubMed ID: 32797228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
    Elong Ngono A; Shresta S
    Front Immunol; 2019; 10():1316. PubMed ID: 31244855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of SARS-CoV-2 antibodies in febrile patients from an endemic region of dengue and chikungunya in Peru.
    Tarazona-Castro Y; Troyes-Rivera L; Martins-Luna J; Cabellos-Altamirano F; Aguilar-Luis MA; Carrillo-Ng H; Del Valle LJ; Kym S; Miranda-Maravi S; Silva-Caso W; Levy-Blitchtein S; Del Valle-Mendoza J
    PLoS One; 2022; 17(4):e0265820. PubMed ID: 35395015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus Co-infection: Indian Perspectives.
    Venkatesh U; Ish P; Kumari S; Gupta N; Sharma A
    Disaster Med Public Health Prep; 2022 Oct; 16(5):1769-1771. PubMed ID: 34344496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covert cases of Severe Acute Respiratory Syndrome Coronavirus 2: An obscure but present danger in regions endemic for Dengue and Chikungunya viruses.
    Stringari LL; de Souza MN; de Medeiros Junior NF; Goulart JP; Giuberti C; Dietze R; Ribeiro-Rodrigues R
    PLoS One; 2021; 16(1):e0244937. PubMed ID: 33406122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques.
    Singh T; Miller IG; Venkatayogi S; Webster H; Heimsath HJ; Eudailey JA; Dudley DM; Kumar A; Mangan RJ; Thein A; Aliota MT; Newman CM; Mohns MS; Breitbach ME; Berry M; Friedrich TC; Wiehe K; O'Connor DH; Permar SR
    mBio; 2024 Mar; 15(3):e0316023. PubMed ID: 38349142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2/DENV co-infection: a series of cases from the Federal District, Midwestern Brazil.
    Schulte HL; Brito-Sousa JD; Lacerda MVG; Naves LA; de Gois ET; Fernandes MS; Lima VP; Rassi CHRE; de Siracusa CC; Sasaki LMP; Cerqueira SRPS; de Albuquerque CP; Reis APMG; Gomes CM; Kurizky PS; da Mota LMH; Espindola LS
    BMC Infect Dis; 2021 Jul; 21(1):727. PubMed ID: 34332542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.